Myopathy and parkinsonism in phosphoglycerate kinase deficiency
- PMID: 20151463
- PMCID: PMC8285082
- DOI: 10.1002/mus.21612
Myopathy and parkinsonism in phosphoglycerate kinase deficiency
Abstract
A 25-year-old man with exertional myoglobinuria had no evidence of hemolytic anemia, but he had severe parkinsonism that was responsive to levodopa. Phosphoglycerate kinase (PGK) activity was markedly decreased in muscle, and molecular analysis of the PGK1 gene identified the p.T378P mutation that was recently reported in a patient with isolated myopathy. This case reinforces the concept that PGK deficiency is a clinically heterogeneous disorder and raises the question of a relationship between PGK deficiency and idiopathic juvenile Parkinson disease.
Figures
References
-
- Beutler E PGK deficiency. Br J Haematol 2007;136:3–11. - PubMed
-
- Turner G, Fletcher J, Elber J, Yanagawa Y, Davé V, Yoshida A. Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br J Haematol 1995;91:60–65. - PubMed
-
- Noel N, Flanagan J, Kalko SG, Ramirez Bajo MJ, del Mar Manu M, Garcia Fuster JL, et al. Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br J Haematol 2005;132: 523–529. - PubMed
-
- Spiegel R, Area Gomez E, Akman HO, Krishna S, Horovitz Y, DiMauro S. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromuscul Disord 2009;19:207–211. - PubMed
-
- Valentine WN, Hsieh H, Paglia DE, Anderson HM, Baughan MA, Jaffe ER, et al. Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. N Engl J Med 1969;280:528–534. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
